中文站

Vitreous &Retinal Disease Center

As one of the essential treatment and research institutions of the Tianjin Eye Hospital, the Vitreoretinal Disease Center(VDC) aims to strengthen research and education on detection and treatment of ocular fundus diseases. In 1982, Professor Jingwen Wei pioneered sclera buckling with indirect ophthalmoscopy .From the early1990s, the vitreous surgeries begin to performed. Nowadays, more than 2,000 vitreous microsurgeries were performed each year, and meanwhile more than 20,000 patients with ocular fundus diseases were treated by non-operative measures such as medicine and laser.


The center has built international cooperation and exchange programs with the world's leading experts in America, Japan, Australia, Singapore and so on. There are talent teamwork in Vitreoretinal Disease Center and stable partnership exchange with College of Ophthalmology in Osaka University as a solid foundation for sustainable development. The center has 10 research projects supported by the Ministry of Public Health and Nation Science and Technology Commission over recent years. More than 100 articles were published in international or national core journals and more than 10 professional books were authored or co-authored by this center. Several Science and Technology Progress Awards were given by Tianjin Government.


Our goal is to provide comprehensive, high-quality, and state-of-the-art eye care in an accessible, supportive, caring, and user-friendly environment; resulting in superior outcomes and a high level of satisfaction for patients. (2016.7)